Skip to main content
Clinical Trials/NCT06175039
NCT06175039
Completed
N/A

Investigation of the Efficiency of Pulmonary Rehabilitation With Telerehabilitation Method in Patients With Bronchiectasis

Saglik Bilimleri Universitesi1 site in 1 country35 target enrollmentMay 15, 2023
ConditionsBronchiectasis

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bronchiectasis
Sponsor
Saglik Bilimleri Universitesi
Enrollment
35
Locations
1
Primary Endpoint
The exercise capacity
Status
Completed
Last Updated
last year

Overview

Brief Summary

It is to determine the effectiveness of pulmonary rehabilitation by telerehabilitation method in bronchiectasis patients. The cases meeting the inclusion criteria will be randomized and divided into two groups, the groups will be named as Telerehabilitation Exercise Group (TRGr) and Control Group (CGr).

Detailed Description

Patients diagnosed with bronchiectasis by HRCT by a chest diseases specialist and referred to pulmonary rehabilitation by determining the severity of bronchiectasis with the Modified Reiff Score and Bronchiectasis Severity Index Score will be included in the study. The cases meeting the inclusion criteria will be randomized and divided into two groups, the groups will be named as Telerehabilitation Exercise Group (TRGr) and Control Group (KGr). TRGr will be given online exercises, synchronized 3 days a week, accompanied by a physiotherapist, via videoconference on the group smartphone. As for the KGr group, a pulmonary rehabilitation information brochure will be given to after the initial evaluation. They will be asked to do the exercises on the brochure. The exercise period will be 8 weeks for both groups. Standard medical treatments for both groups will continue.

Registry
clinicaltrials.gov
Start Date
May 15, 2023
End Date
June 4, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Aged 18 and over
  • Diagnosed with bronchiectasis by HRCT
  • Stable clinical state at the time of admission without infection or exacerbation in the previous 3 weeks
  • Know how to use technological devices

Exclusion Criteria

  • A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training
  • Patients with systemic diseases other than bronchiectasis that also affect the lungs, such as systemic lupus erythematosus, infection, interstitial lung disease, lung cancer, heart and kidney failure, which will cause shortness of breath
  • Having balance problems that prevent them from doing exercises
  • Participation in a pulmonary rehabilitation program within the past 12 months

Outcomes

Primary Outcomes

The exercise capacity

Time Frame: Change from baseline incremental shuttle walking distance at 8 weeks

The exercise capacity will be assessed by the incremental shuttle walking test.

Secondary Outcomes

  • Saint George Respiratory Questionnaire (SGRQ) score(Change from baseline SGRQ score at 8 weeks)
  • Peripheral muscle strength(Change from baseline peripheral muscle strength at 8 weeks)
  • Forced expiratory volume in one second (FEV1)(Change from baseline FEV1 at 8 weeks)
  • Leicester Cough Questıonnaıre (LCQ)(Change from baseline LCQ score at 8 weeks)
  • Forced vital capacity (FVC)(Change from baseline FVC at 8 weeks)
  • Respiratory muscle strength(Change from baseline respiratory muscle strength at 8 weeks)
  • Perception of dyspnea(Change from baseline dyspnea perception at 8 weeks)
  • Modified Borg Scale(Change from baseline Modified Borg Scale score at 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials